Clinicopathological analysis of composite lymphoma: A two-case report and literature review
Authors:
Open Access
- 1 January 2020
- journal article
- review article
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 15 (1) , 654-658
Abstract
The objective of this study was to evaluate the clinicopathological features and treatment of composite lymphoma (CL) with cervical lymph node enlargement. In this study, two cases of CL are presented. Biopsies of enlarged cervical lymph nodes by excision revealed two distinct types of lymphomas. The diagnoses were confirmed by routine histopathology, immunohistochemistry, in situ hybridization, polymerase chain reactions and flow cytometry. Case 1 was diagnosed with Hodgkin’s lymphoma and cytotoxic T-cell lymphoma complicated by Epstein–Barr virus infection. Case 2 was diagnosed with diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma. Case 1 received one cycle of adriamycin, bleomycin, vincristine and dacarbazine (ABVD regimen) combined with chidamide, followed by one cycle of gemcitabine and dexamethasone (GDP regimen) combined with chidamide, and then oral acyclovir. The patient achieved stable disease, but was lost to follow-up. Case 2 received eight cycles of cyclophosphamide, pirarubicin, vincristine and dexamethasone (CTOP regimen) combined with chidamide, and the patient achieved complete remission. Nine months later, relapse was confirmed. She received chidamide monotherapy for 3 months, which was then terminated. One year later, the patient underwent progressive disease and died. CL is a kind of rare disease. Due to the complexity of CL, clinicians should consider both disease components in order to increase the likelihood of effective treatment. This is important.Keywords
This publication has 10 references indexed in Scilit:
- PB1826 COMPOSITE LYMPHOMA CONTAINING MANTLE CELL AND PERIPHERAL T‐CELL LYMPHOMA, NOT OTHERWISE SPECIFIED: A REPORT OF 2 CASES TREATED WITH UP‐FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION.HemaSphere, 2019
- Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphomaMedicine, 2018
- Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in ChinaJournal of Hematology & Oncology, 2017
- A Patient with Supraclavicular Lymphadenopathy and Anterior Mediastinal Mass Presenting as a Rare Case of Composite Lymphoma: A Case Report and Literature ReviewCase Reports in Oncology, 2016
- Composite primary breast diffuse large B-cell lymphoma and T lymphoblastic leukemia/lymphoma: report of a case and review of literature.2015
- Composite lymphoid neoplasm of B-cell and T-cell origins: a pathologic study of 14 casesHuman Pathology, 2014
- A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.2013
- Clinicopathological analysis of a composite lymphoma containing both T‐ and B‐cell lymphomasPathology International, 2012
- Primary Cutaneous, Composite, Epstein-Barr Virus-Associated, Diffuse Large B-cell Lymphoma and Peripheral T-cell LymphomaThe American Journal of Dermatopathology, 2011
- Usefulness of Multiparametric Flow Cytometry in Detecting Composite LymphomaAmerican Journal of Clinical Pathology, 2011